Fotemustine, teniposide and dexamethasone versus high-dose methotrexate plus cytarabine in newly diagnosed primary CNS lymphoma: a randomised phase 2 trial

Overview of attention for article published in Journal of Neuro-Oncology, August 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 24 Dimensions

Readers on

mendeley: 35 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 13,263 followers.

RT @JNeurooncol: #FreeArticle: FTD (fotemustine, teniposide, and dexamethasone) chemotherapy may be a safe treatment option for patients wi…

17 Nov 2018

Reply Repost Favourite

RT @JNeurooncol: #FreeArticle: FTD (fotemustine, teniposide, and dexamethasone) chemotherapy may be a safe treatment option for patients wi…

17 Nov 2018

Reply Repost Favourite

#FreeArticle: FTD (fotemustine, teniposide, and dexamethasone) chemotherapy may be a safe treatment option for patients with primary CNS lymphoma - Bcl-6 expression may be associated with increased survival in these patients. https://t.co/Qwuo0rExVz https:

16 Nov 2018

Reply Repost Favourite

Fotemustine, teniposide and dexamethasone versus high-dose methotrexate plus cytarabine in newly diagnosed primary CNS lymphoma: a randomised phase 2 trial. #lymphoma #lymsm https://t.co/KXURKunogB

16 Aug 2018

Reply Repost Favourite